Annual ROE
-50.30%
-79.59%-271.73%
December 31, 2023
Summary
- As of February 12, 2025, NMRA annual return on equity is -50.30%, with the most recent change of -79.59% (-271.73%) on December 31, 2023.
- During the last 3 years, NMRA annual ROE has fallen by -155.48% (-147.82%).
- NMRA annual ROE is now -147.82% below its all-time high of 105.18%, reached on December 1, 2020.
Performance
NMRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-73.63%
-12.28%-20.02%
September 30, 2024
Summary
- As of February 12, 2025, NMRA quarterly return on equity is -73.63%, with the most recent change of -12.28% (-20.02%) on September 30, 2024.
- Over the past year, NMRA quarterly ROE has increased by +40.18% (+35.30%).
- NMRA quarterly ROE is now -163.10% below its all-time high of 116.68%, reached on September 1, 2021.
Performance
NMRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NMRA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -271.7% | +35.3% |
| 3 y3 years | -147.8% | -191.7% |
| 5 y5 years | - | -191.7% |
NMRA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -168.9% | at low | -170.7% | +51.3% |
| 5 y | 5-year | -147.8% | at low | -163.1% | +51.3% |
| alltime | all time | -147.8% | at low | -163.1% | +51.3% |
Neumora Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -73.63%(+20.0%) |
| Jun 2024 | - | -61.35%(-46.1%) |
| Mar 2024 | - | -113.81%(-24.7%) |
| Dec 2023 | -50.30%(-271.7%) | -151.16%(-245.2%) |
| Sep 2023 | - | 104.09%(+279.6%) |
| Jun 2023 | - | 27.42%(-6.6%) |
| Mar 2023 | - | 29.35%(-9.7%) |
| Dec 2022 | 29.29% | 32.52%(-9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | 35.84%(-55.4%) |
| Jun 2022 | - | 80.33%(+0.2%) |
| Mar 2022 | - | 80.18%(+5.7%) |
| Dec 2021 | 72.97%(-30.6%) | - |
| Dec 2021 | - | 75.86%(-35.0%) |
| Sep 2021 | - | 116.68%(+110.5%) |
| Jun 2021 | - | 55.43%(+48.2%) |
| Mar 2021 | - | 37.40%(+76.5%) |
| Dec 2020 | 105.18% | 21.19% |
FAQ
- What is Neumora Therapeutics annual return on equity?
- What is the all time high annual ROE for Neumora Therapeutics?
- What is Neumora Therapeutics annual ROE year-on-year change?
- What is Neumora Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly ROE year-on-year change?
What is Neumora Therapeutics annual return on equity?
The current annual ROE of NMRA is -50.30%
What is the all time high annual ROE for Neumora Therapeutics?
Neumora Therapeutics all-time high annual return on equity is 105.18%
What is Neumora Therapeutics annual ROE year-on-year change?
Over the past year, NMRA annual return on equity has changed by -79.59% (-271.73%)
What is Neumora Therapeutics quarterly return on equity?
The current quarterly ROE of NMRA is -73.63%
What is the all time high quarterly ROE for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly return on equity is 116.68%
What is Neumora Therapeutics quarterly ROE year-on-year change?
Over the past year, NMRA quarterly return on equity has changed by +40.18% (+35.30%)